Author

Yalda Bravo

Observed name: Bravo, Yalda

Observed institutions: Sanford Burnham Prebys Medical Discovery Institute, National Cancer Institute

OpenAlex ID: A5108107109

Phosphomannose Isomerase Inhibitors Improve N-Glycosylation in Selected Phosphomannomutase-deficient Fibroblasts

2011 · Vandana Sharma, Mie Ichikawa, et al. · Journal of Biological Chemistry · 48

Potent, Selective, and Orally Available Benzoisothiazolone Phosphomannose Isomerase Inhibitors as Probes for Congenital Disorder of Glycosylation Ia

2011 · Russell Dahl, Yalda Bravo, et al. · Journal of Medicinal Chemistry · 47

Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor

2017 · Anthony B. Pinkerton, Eduard Sergienko, et al. · Bioorganic & Medicinal Chemistry Letters · 46

A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo

2015 · Davorka Messmer, Kymmy Lorrain, et al. · Molecular Medicine · 43

In vitro and in vivo pharmacology of NXT629, a novel and selective PPARα antagonist

2017 · Karin J. Stebbins, Alex R. Broadhead, et al. · European Journal of Pharmacology · 30

Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1

2014 · Yalda Bravo, Peter Teriete, et al. · Bioorganic & Medicinal Chemistry Letters · 24

Identification of the first potent, selective and bioavailable PPARα antagonist

2014 · Yalda Bravo, Christopher S. Baccei, et al. · Bioorganic & Medicinal Chemistry Letters · 13

Discovery of potent and selective PPARα/δ dual antagonists and initial biological studies

2018 · Jason D. Jacintho, Christopher S. Baccei, et al. · Bioorganic & Medicinal Chemistry Letters · 9

Inhibition of Fatty Acid Oxidation Leads to Apoptosis of Resting and Proliferating Chronic Lymphocytic Leukemia Cells in Vitro

2012 · Davorka Messmer, Kymmy Lorrain, et al. · Blood · 1

Erratum to: A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo

2015 · Davorka Messmer, Kymmy Lorrain, et al. · Molecular Medicine

Table 7, Summary of in vitro ADMET/PK Properties of GP55 Agonist Probe(s)

2011 · Susanne Heynen‐Genel, Russell Dahl, et al.

Table 3, SAR of Probe CID 15945391 [ML186]

2011 · Susanne Heynen‐Genel, Russell Dahl, et al.

Table 8, Calculated properties of the GPR55 Agonist Probes

2011 · Susanne Heynen‐Genel, Russell Dahl, et al.

Table 5, SAR of Probe CID 2440433 [ML184]

2011 · Susanne Heynen‐Genel, Russell Dahl, et al.

Figure 2, GPR55 Example Images of Positive and Negative Controls: Effect of 25 μM agonist LPI (left panel) compared to DMSO control (right panel)

2011 · Susanne Heynen‐Genel, Russell Dahl, et al.

Works count: 17

Citation count: 261

H-index: 8

I10-index: 7